Chapter One - Dyes and Dreams

CHAPTER ONE

Dyes and Dreams

IT ALL STARTS with coal tar.

Not medicine. Not agriculture. Not war. Just sludge. Thick, black, industrial waste from the bottom of a coal furnace. In the 1800s, it had no value. Then chemists figured out you could turn it into color.

In 1863, Friedrich Bayer and Johann Friedrich Weskott founded a company to do exactly that. They set up shop in Barmen, Germany. A city surrounded by coal, factories, and the booming textile industry. The goal was simple: make synthetic dyes from chemical waste and sell them to people who wanted brighter clothes.

And it worked.

Bayer’s early success came from aniline dyes. Bold, brilliant colors that didn’t fade. Suddenly, coal tar was gold. Germany led the world in dye chemistry, and Bayer became part of that wave. They weren’t alone, but they were fast, and they were smart. The company grew. Labs expanded. Profits rose.

And then something happened.

The same chemistry that made dyes could be used for something else, drugs. The early industrial chemists started testing their formulas not just on fabric, but on bodies. They were looking for medical breakthroughs. Or sometimes, just a reaction.

The line between color and cure started to blur.

Bayer leaned in. Research accelerated. They hired more scientists. Built more labs. Started isolating compounds that could reduce fever, numb pain, or suppress a cough. The goal was no longer fashion. It was transformation. Chemical transformation of sickness, suffering, and markets.

The dye company was becoming a drug company.

By the end of the century, Bayer wasn’t just selling color anymore.

They were selling control.